person · Reporting owner

Mackin James P

Disclosed activity across 2 companies

Tapewire entity: 21411
SEC CIK: 0001408470

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ARTIVION, INC.AORT · Entity 4767	President & CEO	August 19, 2026	August 20, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARTIVION, INC.

Report date August 19, 2026 · Filed August 20, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	877,275	Reported balance After 2026-08-19 transaction · row 1 1 source row Row 1 · 2026-08-19 · Sale · Disposed 70,000 · Balance 877,275 F1: Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Wright Medical Group N.V.

Report date November 11, 2020 · Filed November 13, 2020

Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	Reported balance After 2020-11-11 transaction · row 1 1 source row Row 1 · 2020-11-11 · Other · Disposed 11,720 · Balance 0 F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 11,720 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.84 · Expires 2029-07-26	Direct	Reported balance After 2020-11-11 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-11-11 · Disposition to issuer · Disposed 11,691 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.49 · Expires 2028-07-24	Direct	Reported balance After 2020-11-11 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-11-11 · Disposition to issuer · Disposed 9,907 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 11,720 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)

F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 23, 2023 Filed Mar 1, 2023 23:36 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock	42,148	$0.00	$0.00	Disclosure SEC source: 0000784199-23-000048 · wf-form4_167771379285071.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,037 F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date. Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:36 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock	28,282	$0.00	$0.00	Disclosure SEC source: 0000784199-23-000048 · wf-form4_167771379285071.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,534 F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023. Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:29 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	2,139	$13.96	$29,860.44	Disclosure SEC source: 0000784199-23-000022 · wf-form4_167698613905019.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,252 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:29 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	8,553	$13.96	$119,399.88	Disclosure SEC source: 0000784199-23-000022 · wf-form4_167698613905019.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,391 F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:29 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	2,740	$13.96	$38,250.40	Disclosure SEC source: 0000784199-23-000022 · wf-form4_167698613905019.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,944 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 14, 2023 Filed Feb 16, 2023 22:36 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionStock Options (Right to buy) · Derivative	65,549	$10.24 Strike: $10.24	$671,221.76	Disclosure SEC source: 0000784199-23-000016 · wf-form4_167658695692379.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Commn Stock · 65,549 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. Read SEC document
February 14, 2023 Filed Feb 16, 2023 22:36 UTC	ARTIVION, INC. AORT · Entity 4767	SaleCommon Stock	56,500	$13.22	$747,206.85	Disclosure SEC source: 0000784199-23-000016 · wf-form4_167658695692379.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,684 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 F2 · price: Reflects the price of $ 13.224856 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document
February 14, 2023 Filed Feb 16, 2023 22:36 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionCommon Stock	65,549	$10.24	$671,221.76	Disclosure SEC source: 0000784199-23-000016 · wf-form4_167658695692379.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 Read SEC document
November 08, 2022 Filed Nov 10, 2022 14:13 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock · Derivative	280,435	$0.00 Strike: $11.03	$0.00	Disclosure SEC source: 0000784199-22-000201 · wf-form4_166808958465093.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,435 Underlying: Commn Stock · 280,435 shares Expires 2029-11-08 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document
November 08, 2022 Filed Nov 10, 2022 14:13 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock	116,954	$0.00	$0.00	Disclosure SEC source: 0000784199-22-000201 · wf-form4_166808958465093.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,635 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document
March 05, 2022 Filed Mar 7, 2022 21:33 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	2,228	$21.69	$48,325.32	Disclosure SEC source: 0000784199-22-000112 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,681 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
March 05, 2022 Filed Mar 7, 2022 21:33 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	10,801	$21.69	$234,273.69	Disclosure SEC source: 0000784199-22-000112 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,909 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document
February 23, 2022 Filed Feb 24, 2022 21:32 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock · Derivative	126,546	$0.00 Strike: $18.44	$0.00	Disclosure SEC source: 0000784199-22-000092 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,546 Underlying: Common Stock · 126,546 shares Expires 2029-02-23 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document
February 23, 2022 Filed Feb 24, 2022 21:32 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock	47,627	$0.00	$0.00	Disclosure SEC source: 0000784199-22-000092 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,710 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document
February 19, 2022 Filed Feb 22, 2022 22:00 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	3,204	$17.75	$56,871.00	Disclosure SEC source: 0000784199-22-000072 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,083 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 17, 2022 Filed Feb 22, 2022 12:30 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	7,923	$17.50	$138,652.50	Disclosure SEC source: 0000784199-22-000050 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,287 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 17, 2022 Filed Feb 22, 2022 12:30 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock	23,838	$0.00	$0.00	Disclosure SEC source: 0000784199-22-000050 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,210 F3 · shares: Represents performance stock units granted on Feb 17, 2021. Hundred percent (100%) were issued on Feb 17, 2022. Read SEC document
February 17, 2022 Filed Feb 22, 2022 12:30 UTC	ARTIVION, INC. AORT · Entity 4767	Tax withholdingCommon Stock	8,210	$17.50	$143,675.00	Disclosure SEC source: 0000784199-22-000050 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,372 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 17, 2022 Filed Feb 22, 2022 12:30 UTC	ARTIVION, INC. AORT · Entity 4767	GrantCommon Stock	36,404	$0.00	$0.00	Disclosure SEC source: 0000784199-22-000050 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,582 F1 · shares: Represents performance stock units granted on Feb 17, 2021. Fifty percent (50%) were issued on Feb 17, 2022. The remaining shares earned in connection with the Feb 2021 grant will be eligible to vest and be issued as follows: 25% on 02/17/2023, and 25% on 02/17/2024, assuming continued employment on the relevant vesting date. Read SEC document
February 10, 2022 Filed Feb 11, 2022 13:41 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionStockOption(RightToBuy) · Derivative	10,639	$11.00 Strike: $11.00	$117,029.00	Disclosure SEC source: 0000784199-22-000030 · certent-form4.xml · derivative · entry 6 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,639 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document
February 10, 2022 Filed Feb 11, 2022 13:41 UTC	ARTIVION, INC. AORT · Entity 4767	SaleCommon Stock	10,639	$17.86	$189,997.65	Disclosure SEC source: 0000784199-22-000030 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 F3 · price: Reflects weighted average price. Range of prices were between $17.69 to $18.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document
February 10, 2022 Filed Feb 11, 2022 13:41 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionCommon Stock	10,639	$11.00	$117,029.00	Disclosure SEC source: 0000784199-22-000030 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 Read SEC document
February 09, 2022 Filed Feb 11, 2022 13:41 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionStockOption(RightToBuy) · Derivative	10,638	$11.00 Strike: $11.00	$117,018.00	Disclosure SEC source: 0000784199-22-000030 · certent-form4.xml · derivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,639 Underlying: Common Stock · 10,638 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document
February 09, 2022 Filed Feb 11, 2022 13:41 UTC	ARTIVION, INC. AORT · Entity 4767	SaleCommon Stock	10,638	$18.14	$192,989.28	Disclosure SEC source: 0000784199-22-000030 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 F2 · price: Reflects weighted average price. Range of prices were between $17.93 to $18.36. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document
February 09, 2022 Filed Feb 11, 2022 13:41 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionCommon Stock	10,638	$11.00	$117,018.00	Disclosure SEC source: 0000784199-22-000030 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 Read SEC document
February 08, 2022 Filed Feb 10, 2022 12:53 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionStockOption(RightTo Buy) · Derivative	10,638	$11.00 Strike: $11.00	$117,018.00	Disclosure SEC source: 0000784199-22-000018 · certent-form4.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,277 Underlying: Common Stock · 10,638 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document
February 08, 2022 Filed Feb 10, 2022 12:53 UTC	ARTIVION, INC. AORT · Entity 4767	SaleCommon Stock	10,638	$17.75	$188,771.31	Disclosure SEC source: 0000784199-22-000018 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 F2 · price: Reflects weighted average price. Range of prices were between $17.4 to $17.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document
February 08, 2022 Filed Feb 10, 2022 12:53 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionCommon Stock	10,638	$11.00	$117,018.00	Disclosure SEC source: 0000784199-22-000018 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:38 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionStockOption(Right To Buy) · Derivative	10,638	$11.00 Strike: $11.00	$117,018.00	Disclosure SEC source: 0000784199-22-000016 · certent-form4.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,915 Underlying: Common Stock · 10,638 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:38 UTC	ARTIVION, INC. AORT · Entity 4767	SaleCommon Stock	10,638	$17.30	$184,052.29	Disclosure SEC source: 0000784199-22-000016 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 F2 · price: Reflects weighted average price. Range of prices were between $16.90 to $17.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document
February 07, 2022 Filed Feb 8, 2022 21:38 UTC	ARTIVION, INC. AORT · Entity 4767	Exercise / conversionCommon Stock	10,638	$11.00	$117,018.00	Disclosure SEC source: 0000784199-22-000016 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC	ARTIVION, INC. CRY · Entity 4767	Exercise / conversionStockOption(Right To Buy) · Derivative	29,469	$10.18 Strike: $10.18	$299,994.42	Disclosure SEC source: 0000784199-21-000123 · certent-form4.xml · derivative · entry 6 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,469 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC	ARTIVION, INC. CRY · Entity 4767	Exercise / conversionStockOption(Right To Buy) · Derivative	16,265	$10.18 Strike: $10.18	$165,577.70	Disclosure SEC source: 0000784199-21-000123 · certent-form4.xml · derivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,265 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC	ARTIVION, INC. CRY · Entity 4767	SaleCommon Stock	29,469	$28.00	$825,132.00	Disclosure SEC source: 0000784199-21-000123 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 17, 2021 F2 · price: Reflects the price of $28 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC	ARTIVION, INC. CRY · Entity 4767	Exercise / conversionCommon Stock	29,469	$10.18	$299,994.42	Disclosure SEC source: 0000784199-21-000123 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 17, 2021 Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC	ARTIVION, INC. CRY · Entity 4767	SaleCommon Stock	16,265	$28.00	$455,420.00	Disclosure SEC source: 0000784199-21-000123 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 17, 2021 F2 · price: Reflects the price of $28 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document
April 30, 2021 Filed May 4, 2021 20:13 UTC	ARTIVION, INC. CRY · Entity 4767	Exercise / conversionCommon Stock	16,265	$10.18	$165,577.70	Disclosure SEC source: 0000784199-21-000123 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 17, 2021 Read SEC document
March 12, 2021 Filed Mar 15, 2021 20:29 UTC	ARTIVION, INC. CRY · Entity 4767	Tax withholdingCommon Stock	2,674	$25.05	$66,983.70	Disclosure SEC source: 0000784199-21-000099 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
March 12, 2021 Filed Mar 15, 2021 20:29 UTC	ARTIVION, INC. CRY · Entity 4767	Tax withholdingCommon Stock	13,092	$25.05	$327,954.60	Disclosure SEC source: 0000784199-21-000099 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,852 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document
March 05, 2021 Filed Mar 10, 2021 12:44 UTC	ARTIVION, INC. CRY · Entity 4767	Tax withholdingCommon Stock	1,487	$24.44	$36,342.28	Disclosure SEC source: 0000784199-21-000076 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,944 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 23, 2021 Filed Feb 25, 2021 22:56 UTC	ARTIVION, INC. CRY · Entity 4767	Tax withholdingCommon Stock	4,383	$25.41	$111,372.03	Disclosure SEC source: 0000784199-21-000053 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,431 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document
February 23, 2021 Filed Feb 25, 2021 22:56 UTC	ARTIVION, INC. CRY · Entity 4767	GrantCommon Stock	28,415	$0.00	$0.00	Disclosure SEC source: 0000784199-21-000053 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,814 F1 · shares: Represents performance stock units granted on Feb 19, 2020 and repriced on Feb 8, 2021. Fifty percent (50%) were issued on Feb 23, 2021. The remaining shares earned in connection with the Feb 2020 grant will be eligible to vest and be issued as follows: 25% on 02/19/2022, and 25% on 02/19/2023, assuming continued employment on the relevant vesting date. Read SEC document
February 17, 2021 Filed Feb 19, 2021 21:26 UTC	ARTIVION, INC. CRY · Entity 4767	GrantStock Options (Right to Buy) · Derivative	93,519	$0.00 Strike: $24.90	$0.00	Disclosure SEC source: 0000784199-21-000029 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,519 Underlying: Common Stock · 93,519 shares Expires 2028-02-17 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document
February 17, 2021 Filed Feb 19, 2021 21:26 UTC	ARTIVION, INC. CRY · Entity 4767	GrantCommon Stock	33,125	$0.00	$0.00	Disclosure SEC source: 0000784199-21-000029 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,399 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document
November 11, 2020 Filed Nov 13, 2020 15:14 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Disposition to issuerStock Option (right to buy) · Derivative	9,907	Not disclosed Strike: $24.49	Not disclosed	Disclosure SEC source: 0001235802-20-000125 · primary_doc.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,907 shares Expires 2028-07-24 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document
November 11, 2020 Filed Nov 13, 2020 15:14 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Disposition to issuerStock Option (right to buy) · Derivative	11,691	Not disclosed Strike: $27.84	Not disclosed	Disclosure SEC source: 0001235802-20-000125 · primary_doc.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,691 shares Expires 2029-07-26 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document
November 11, 2020 Filed Nov 13, 2020 15:14 UTC	Wright Medical Group N.V. WMGI · Entity 145358	OtherOrdinary Shares, par value EUR 0.03 per share	11,720	$30.75	$360,390.00	Disclosure SEC source: 0001235802-20-000125 · primary_doc.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 11,720 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement) Read SEC document
September 16, 2020 Filed Sep 16, 2020 17:23 UTC	ARTIVION, INC. CRY · Entity 4767	GrantCommon Stock	7,500	$16.74	$125,523.75	Disclosure SEC source: 0000784199-20-000190 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,274 Read SEC document
September 16, 2020 Filed Oct 1, 2020 13:00 UTC Amendment	ARTIVION, INC. CRY · Entity 4767	PurchaseCommon Stock	7,500	$16.74	$125,523.75	Disclosure SEC source: 0000784199-20-000196 · certent-form4a.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,274 F1 · price: Reflects open market purchase by reporting person. The original form 4 noted the transaction as an acquired grant in error. Read SEC document
May 05, 2020 Filed May 7, 2020 21:39 UTC	ARTIVION, INC. CRY · Entity 4767	GrantPhantom Stock · Derivative	3,832	Not disclosed	Not disclosed	Disclosure SEC source: 0000784199-20-000131 · certent-form4.xml · derivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,774 Underlying: Phantom Stock · 3,832 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.